Carie Boyd Pharmaceuticals specializes in compounding a diverse range of medications for office use and individual patient needs. We proudly operate as an FDA-registered office-use outsourced compounding facility (503B) and a specialty prescription compounding pharmacy (503A). Through these avenues, we efficiently distribute and dispense our compounded medications to healthcare providers and patients nationwide. Our state-of-the-art facility adheres to rigorous FDA regulations and standards, ensuring the highest quality medications for healthcare practitioners, clinics, hospitals, group purchasing organizations, and other provider networks. With our comprehensive offerings, we possess the unique capability to produce nearly any custom-manufactured or compounded medication required by our healthcare partners and their patients. Originally established in 1965 as a modest community pharmacy in the Dallas-Ft. Worth area, our journey began by collaborating with general practitioners, urologists, and OB-GYNs. Our expertise in hormone medications swiftly earned us a reputable status in the industry. We emerged as a leading supplier of implantable subcutaneous hormone pellets and spearheaded the development of the modern automated pellet manufacturing process. In 2015, we became one of the pioneering independently owned facilities to register with the FDA as an outsourced compounding facility (503B), exclusively serving healthcare professionals. This significant milestone propelled our growth and positioned us as a trusted partner in the healthcare industry. In response to our expanding team and manufacturing capacity, we strategically relocated to our present-day facility in 2019. This move enabled us to enhance our capabilities further and deliver exceptional products and services to our valued partners. Today, Carie Boyd Pharmaceuticals is an esteemed industry leader, continuously seeking opportunities to support and cater to our healthcare partners.